Purchase Order HHSF223201410363A
- Not listed
- This federal contract award to Caitta Inc., a certified economically disadvantaged woman-owned small business (EDWOSB), is for the procurement of an LC-MS MS triple quad w/ QTRAP capabilities. The $459,234.72 firm fixed price contract was awarded by the Food and Drug Administration (FDA), a civilian agency. The contract has no set-aside designation. Caitta Inc. is a strategic federal contractor that specializes in providing scientific instrumentation, analytical equipment, and professional...
- This is a $149,419.03 firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The contract is for the procurement of an ultra-performance liquid chromatography (UPLC) system with a diode array detector (DAD), refrigerated sample compartment, auxiliary application programming interface (API) for a liquid chromatography-mass spectrometry (LC-MS)...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB). The $1,092,204.46 contract is for the delivery of two mass spectrometers, with a completion date of September 22, 2027. Caitta Inc. is a strategic federal contractor focused on providing scientific instrumentation, analytical equipment, and professional services to...
- The U.S. Food and Drug Administration (FDA) awarded a $1,516,025.52 firm fixed-price purchase order contract to Caitta Inc., an SBA-certified Economically Disadvantaged Women-Owned Small Business (EDWOSB), to provide a Liquid Chromatography Coupled with High Resolution-Accurate Mass Tandem Mass Spectrometer System (LC-HRAM-MS/MS). This contract has a completion date of November 19, 2024 and was set aside for small businesses. Caitta Inc. is an experienced provider of scientific instrumentation...
- This is a $535,268.72 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB). The contract is for the delivery of a quadrupole-orbitrap high resolution mass spectrometer with liquid chromatograph. This specialized scientific instrumentation will support the FDA's analytical and regulatory missions. The contract has an ultimate completion date of October 17, 2026 and...
- The U.S. Food and Drug Administration (FDA) awarded a $704,138.55 firm-fixed-price purchase order to Caitta Inc., an SBA-certified Economically Disadvantaged Women-Owned Small Business (EDWOSB), for the procurement of an ultra-high sensitivity, liquid chromatography-hybrid triple quadrupole-linear accelerator trap mass spectrometer (LC-MS/MS) system. This purchase order is set aside for small businesses and has a completion date of September 19, 2027. Caitta Inc. is an experienced federal...
- The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a firm fixed-price purchase order contract to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB), for a new annual maintenance agreement for a SCIEX QTRAP 5500 LC-MS/MS system. The contract has a ceiling value of $168,262.56 and a completion date of February 19, 2029. Caitta Inc. is an experienced provider of scientific and technical services to federal agencies,...
- The Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB), for the procurement of a Thermo Fisher Vanquish Neo Ultra-High-Performance Liquid Chromatography (UHPLC) system and an Easy-Spray Sources (ESI) kit. The $101,942.76 contract includes installation, testing, training, and warranty support. This award was made under a total small business set-aside solicitation for...
- This federal contract award, valued at $61,340.38, was made by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The contract is for the provision of two identical 4000-QTRAP mass spectrometers, which are specialized scientific instruments used for chemical analysis. The contract is a sole-source 8(a) set-aside, indicating that it was awarded to a small business participating in the...
- The U.S. Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order to Caitta Inc., an SBA-certified Economically Disadvantaged Women-Owned Small Business (EDWOSB), for the delivery of a BENCHTOP HYBRID TRIPLE QUADRUPOLE-LINEAR ION TRAP MASS SPECTROMETER. The $309,355.36 contract has an ultimate completion date of September 19, 2025. This contract was set aside for woman-owned small businesses and was awarded under the FDA's $999,000 multiple-award Government Wide Acquisition...
This federal contract award is for the procurement of a 6500 UPLC-MS MS SYSTEM, a highly specialized scientific instrument, by the Food and Drug Administration (FDA), a civilian government agency. The contract was awarded to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant, through a sole-source set-aside. The fixed-price contract has a ceiling value of $506,179.49 and a completion date of October 16, 2016. Caitta Inc. is a strategic federal contractor that provides advanced scientific equipment and specialized professional services to various government agencies, including the FDA, NIH, CDC, NIST, and USDA. The company holds a significant Federal Supply Schedule contract with the GSA, enabling it to supply a range of epidemiological, public health, research, and administrative services to civilian federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Close Out | $0 | 6/10/25 | |
| 1 | Exercise an Option | $46.9k | 10/19/15 | |
| Not listed | Not listed | $459.2k | 9/16/14 |